Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
SpotOn Marketing CommunicationsFounder
Jan. 2006New York, United StatesPrincipal and Founder of SpotOn Marketing Communications which provides marketing strategy, branding, graphic design, website and app development, social and digital marketing, and other communication and investor relations solutions. Client experience includes: NanoHive Medical, Pixium Vision, Bonesupport, Anika Therapeutics, FacetLink, Metabiota, Boston Scientific, Carl Zeiss and Johnson & Johnson. (www.spotonmarcom.com)
iBenefitsFounder
Jan. 2015 - Jan. 2022New York, United StatesFounded, developed and launched iBenefits, an online web and app based tool for Insurance agencies and brokers to disseminate employee benefit information to employers, clients and end users. iBenefits currently serves over 3,500 employers, enjoys 90%+ gross margins and is virtually a passive income stream, with little client support required.
Access HealthCare IncCo-Founder
Sep. 2005 - Jan. 2007San Diego, California, United StatesCo-founder of a development stage retail health care provider based on the idea of a convergence of healthcare and retail. Established company, built operational management team and strategic advisory board, performed primary consumer market research, due diligence of market size, growth potential, financial analyses, and structured all legal aspects of the business. Business development efforts included business plan development, fund raising efforts, corporate strategic partnering and retailer partner presentations.
Whitelight SystemsSr. Consultant
Jan. 1996 - Jan. 2001Worked with clients to design, develop and implement enterprise wide analytic applications using database and application server technologies to analyze portfolio risk, improve profitability and understand customer behavior through customer profiling. Clients included GE Capital, Sybase, and N.E.W. Customer Service Companies, Inc. Pioneered the design and implementation of analytic applications that were the first of their kind in their respective industry and affected more than $500 million. Developed an expertise in database technology, analytic application server technology, enterprise application software design, development, testing and implementation. Contributed to marketing, and corporate strategic positioning.
LIFESCIENCE ECONOMICS / 1997Director of Research and Analysis
Jan. 1997 - Jan. 1997Palo Alto, California, United StatesDirected and coordinated research and analysis efforts of six direct reports. Responsible for building and managing multifaceted project teams for technology assessments, venture capital opportunity profiles, corporate turn-arounds, strategy formulation and implementation, and S1 registration documentation. Developed operating procedures for project management, budgeting, scheduling, contract and billing. Delivered capabilities presentations resulting in lead generation and new business.
Syntex Labs (Acquired by Roche)Analyst
Jan. 1991 - Jan. 1994Palo Alto, CASenior Analyst: Marketing Intelligence, Naprosyn /Anaprox, August 1993 - April 1994 Managed research efforts and product forecasts for Naprosyn and Anaprox, including patent expiration strategy and the Naprosyn EC launch efforts. Responsible for formulation and implemention of product launch strategy. Senior Decision Analyst, January 1993 - August 1993
Responsible for the commercial assessment of products in clinical development. Sales volume affected was greater than $2 billion. Provided major analytic support on decisions affecting products in development through interaction with product development teams, clinical researchers and outside market research vendors. Made recommendations and presentations on go/no go decisions to Senior Management. Identified, implemented and trained personnel in new forecasting methodologies adopted by the Corporation for global forecasting. Decision Analyst, August 1991 - January 1993
Responsible for the management, analysis and execution of Syntex Lab’s in-line product forecasts in excess of $1 billion. Balanced opposing interests of internal customers while maintaining the forecast’s analytical integrity. Consulted on sales force strategy projects resulting in optimization of profits through call positioning. Responsible for ad hoc analyses of line extension forecasts, licensing opportunities, pricing strategies and the impact of managed health care on forecasted sales.
TripleTreePrincipal Healthcare Investment Banking
Jun. 2006 - Jun. 2007San Diego, California, United StatesPrincipal July 2006 – July 2007
Focus on wireless healthcare and retail health startup companies. Worked on venture funding for a retail health initiative, eq life and LifeComm, a wireless healthcare company, spun out of Best Buy, and Qualcomm respectively. Published an extensive report on the emerging wireless healthcare market as a business development aid.
The Seidler CompaniesManaging Director and Equity Research Analyst
Jan. 2002 - Jan. 2004Los Angeles, California, United StatesManaging Director Senior Equity Research Analyst Medical Products December 2002 – July 2004 Covered eight companies (LSCP, ISRG, RITA, AMI, EBIO, QDEL, AMEV, CIPH and ILMN) in minimally invasive medical device, medical instrumentation space, molecular/point of care diagnostics and biotechnology industries. Performance since initiating coverage was approximately 110% return vs. Dow Jones (+19%) and NASQAQ (+40%). Responsible for initiating and launching an emerging-growth life science company investment conference with 23 presenting companies in January 2004. Vice President Senior Equity Research Analyst Healthcare/Biotech June 2002 – December 2002
Responsible for building a healthcare equity research practice and coverage universe focused on medical device, biotechnology, and healthcare companies.
Roth Capital PartnersPrincipal
Jan. 2001 - Jan. 2002Newport Beach, California, United StatesClosed over $35 million in public and private biopharmaceutical financings. Leveraged network of contacts built up over 15 years in the healthcare/biopharmaceutical/buy-side/VC finance industries for potential deals. The majority of contacts are involved in start-up (Series A, B) firms employing cutting edge technology with solid business models. Led “road shows” and structured PIPE financings. Led or participated in multiple pitches to perform public or private capital raises and led fairness opinions on M&A activity, and Shareholders’ Rights Plans.
Objective InsightsCo-Founder
Jan. 1994 - Jan. 1996Saratoga, California, United StatesBusiness analysis for the healthcare industry. Build systems and performed portfolio optimization for clients such as Gilead Sciences and Genentech Founder, Managing Director, and CFO May 1994 - January 1997 Founded Objective Insights to provide business analysis to biotechnology and pharmaceutical companies. Self funded firm. Profitable from inception with no debt. Established strong industry presence, grossing over $1 million within first two years. Clients include: Alza, Cibus Pharmaceutical, Genentech, Geron Corporation, Gliead Sciences, Merck, and Pharmacia & Upjohn.
Intch is a Professional Networking App for the Future of WorkSee more people like Mark on Intch
100k+ people
130+ countries
AI matching
Get Intch if you'd like to
70105 people
8
CEO @ AssetData
17
Senior Software Engineer @ American Express
15
Business analysts @ National Flood Services
4270 people
15
Investor relations manager @ Exxonmobil cooperation
18
Student @ PDX Code Guild
15
IOS Engineer @ Abbacore